Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Peyraga

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
International Journal of Clinical Oncology|May 2, 2015
Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric studySéna Yossi, Benjamin Linot, Guillaume Peyraga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 1, 2018
Molecular PET imaging in adaptive radiotherapy: brainGuillaume Peyraga, Nesrine Robaine, Jonathan Khalifa, et al.
Anti-Cancer Drugs|September 27, 2016
Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatinGuillaume Peyraga, Benjamin Linot, Sena Yossi, et al.
Clinical Transplantation|February 10, 2017
Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI)Guillaume Peyraga, Thibaut Lizee, Pierre Gustin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 25, 2017
Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastasesGuillaume Peyraga, Delphine Caron, Thibaut Lizee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2019
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung CancerThibaut Lizée, Ethan Basch, Pierre Trémolières, et al.
Radiation Oncology (London, England)|February 5, 2021
Cranial organs at risk delineation: heterogenous practices in radiotherapy planningGuillaume Vogin, Liza Hettal, Clarisse Bartau, et al.
Cancers|June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted OligodendrogliomasJulia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Clinical Oncology|May 2, 2015
Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric studySéna Yossi, Benjamin Linot, Guillaume Peyraga, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|December 1, 2018
Molecular PET imaging in adaptive radiotherapy: brainGuillaume Peyraga, Nesrine Robaine, Jonathan Khalifa, et al.
Anti-Cancer Drugs|September 27, 2016
Exclusive concurrent radiochemotherapy for advanced head and neck cancers with 'fractionated' 5-fluorouracil and cisplatinGuillaume Peyraga, Benjamin Linot, Sena Yossi, et al.
Clinical Transplantation|February 10, 2017
Treatment of cutaneous and/or soft tissue manifestations of corticosteroids refractory chronic graft versus host disease (cGVHD) by a total nodal irradiation (TNI)Guillaume Peyraga, Thibaut Lizee, Pierre Gustin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 25, 2017
Digestive toxicities after palliative three-dimensional conformal radiation therapy (3D-CRT) for cervico-thoracic spinal metastasesGuillaume Peyraga, Delphine Caron, Thibaut Lizee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 19, 2019
Cost-Effectiveness of Web-Based Patient-Reported Outcome Surveillance in Patients With Lung CancerThibaut Lizée, Ethan Basch, Pierre Trémolières, et al.
Radiation Oncology (London, England)|February 5, 2021
Cranial organs at risk delineation: heterogenous practices in radiotherapy planningGuillaume Vogin, Liza Hettal, Clarisse Bartau, et al.
Cancers|June 28, 2023
A Multigene Signature Associated with Progression-Free Survival after Treatment for IDH Mutant and 1p/19q Codeleted OligodendrogliomasJulia Gilhodes, Adèle Meola, Bastien Cabarrou, et al.
BMC Cancer|February 23, 2019
Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imagingAnne Laprie, Soléakhéna Ken, Thomas Filleron, et al.
Pageof 1